| Filed On | Filing |
|---|---|
| 16 Oct 2026 | DEFA14A |
| 15 Oct 2026 |
8-K: Results of Operations and Financial Condition
MENLO PARK, Calif. – October 15, 2026 — ChronoScale Holdings Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, reported fina... |
| 14 Oct 2026 | 10-Q |
| 09 Oct 2026 | EFFECT |
| 06 Oct 2026 |
Form 4: Davis Scott G., Director
Received 51,626 shares as a grant or award |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
As previously announced, on September 30, 2026, ChronoScale Holdings Corporation, a Nevada corporation (the “Company”) completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. (“Ekso”). In connection with the sale of Ekso (t... |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-8 POS |
| 06 Oct 2026 | S-3 |
| 02 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more
ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit |
| 29 Sep 2026 | DRS |
Loading...
